Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby N Trahair

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Molecular Cancer Research : MCR|November 15, 2017
Targeted Next-Generation Sequencing for Detecting <i>MLL</i> Gene Fusions in LeukemiaSadia Afrin, Christine R C Zhang, Claus Meyer, et al.
Journal of Adolescent and Young Adult Oncology|July 23, 2021
"We Have All This Knowledge to Give, So Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research PrioritiesClarissa E Schilstra, Ursula M Sansom-Daly, Maria Schaffer, et al.
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Journal of Paediatrics and Child Health|October 6, 2018
Enrolment in paediatric oncology early-phase clinical trials: The health-care professionals' perspectiveEden G Robertson, Richard Mitchell, Claire E Wakefield, et al.
NPJ Precision Oncology|February 13, 2021
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumorSumanth Nagabushan, Loretta M S Lau, Paulette Barahona, et al.
Journal of Proteomics|November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approachPatrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Cancers|April 14, 2025
Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond TreatmentClare Parker, Clarissa E Schilstra, Karen McCleary, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Molecular Cancer Research : MCR|November 15, 2017
Targeted Next-Generation Sequencing for Detecting <i>MLL</i> Gene Fusions in LeukemiaSadia Afrin, Christine R C Zhang, Claus Meyer, et al.
Journal of Adolescent and Young Adult Oncology|July 23, 2021
"We Have All This Knowledge to Give, So Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research PrioritiesClarissa E Schilstra, Ursula M Sansom-Daly, Maria Schaffer, et al.
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Journal of Paediatrics and Child Health|October 6, 2018
Enrolment in paediatric oncology early-phase clinical trials: The health-care professionals' perspectiveEden G Robertson, Richard Mitchell, Claire E Wakefield, et al.
NPJ Precision Oncology|February 13, 2021
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumorSumanth Nagabushan, Loretta M S Lau, Paulette Barahona, et al.
Journal of Proteomics|November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approachPatrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Cancers|April 14, 2025
Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond TreatmentClare Parker, Clarissa E Schilstra, Karen McCleary, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Pageof 6